Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: r. c. cummings who wrote (4939)	3/10/1999 2:16:00 PM
From: LT	Respond to of 5736

Hope your right :)) As far as it being old news it's dated today. Appears FDA approval was recently given. Any competition, when you formally had none, is significant, you seem to know what your talking about though, that's comforting.... LT

To: r. c. cummings who wrote (4939)	3/10/1999 5:53:00 PM
From: Cacaito	Read Replies (1) \| Respond to of 5736

The innacuracy (originated in this thread) that the Sprx Bilicheck can not work during phototherapy is just that, false. Fact: For both devices the phototherapy light is turn off during the few seconds needed to do the test. Both are base on same technology. Just call Sprx and find it out. Respironics marketing power is going to quickly gain the customers. The FDA approval of the Sprx Bilicheck will make royalties that CCSI will have to negotiate with a partner more difficult. Expect CCSI to have a single digit percentage royalty.